All Pharma News
price-trendAsk Us
IntraBio Announces FDA Accepts NDA for IB1001 for Niemann-Pick Disease Type C

IntraBio Announces FDA Accepts NDA for IB1001 for Niemann-Pick Disease Type C
ACCESSWIRE
26 Mar 2024
Share Share
IntraBio NPC Phase III Successful Trial

IntraBio NPC Phase III Successful Trial
ACCESSWIRE
29 Jun 2023
Share Share
IntraBio Update

IntraBio Update
ACCESSWIRE
12 Apr 2023
Share Share
IntraBio Completes Recruitment for IB1001 NPC Pivotal Clinical Trial

IntraBio Completes Recruitment for IB1001 NPC Pivotal Clinical Trial
ACCESSWIRE
08 Dec 2022
Share Share
IntraBio Reaches Target Enrollment for IB1001 NPC Pivotal Clinical Trial

IntraBio Reaches Target Enrollment for IB1001 NPC Pivotal Clinical Trial
ACCESSWIRE
22 Nov 2022
Share Share
IntraBio Reports Further Detail On Positive Data From IB1001

IntraBio Reports Further Detail On Positive Data From IB1001
ACESSWIRE
14 Sep 2021
Share Share
IntraBio therapy demonstrates significant benefits for GM2

IntraBio therapy demonstrates significant benefits for GM2
MANUFACTURINGCHEMIST
20 Aug 2021
Share Share
IntraBio Reports Further Detail on Positive Data from IB1001

IntraBio Reports Further Detail on Positive Data from IB1001
ACCESSWIRE
19 Oct 2020
Share Share
IntraBio Reports Positive Data from IB1001 Multinational Clinical Trial

IntraBio Reports Positive Data from IB1001 Multinational Clinical Trial
ACCESSWIRE
30 Sep 2020
Share Share